Stocks start October on a flat note. Tekmira Pharmaceuticals, maker of a possible Ebola treatment, spikes 21%.
Many publicly traded companies spend millions a year for political influence.
Not a member yet?
Get updates on CNNMoney on Twitter
Get updates on CNNMoney on Facebook
Get updates on CNNMoney Tech on Tumblr
Download CNNMoney App for Apple iOS
Connect with CNNMoney via your mobile device
Get the latest breaking news and market data via email
Receive the latest news via RSS